Crux Biolabs: expansion into chemistry
After repeated inquiries from our customer base, Crux Biolabs are pleased to announce their expansion into chemistry analytical services in 2023.
These services will be centred around UHPLC and LCMS instrumentation to be installed in our new, purpose-built lab space. LCMS is a standard tool for the sensitive analysis of drug concentrations in biological matrices, such as in preclinical studies or clinical trials. UHPLC is better suited to assays such as measurement of individual components in drug formulations.
We still have some renovations to complete, but see below a sneak peek of the new lab and stay tuned for further updates – OR get in touch with our team to start planning your 2023 with Crux.